Tyber Medical Announces Licensing of Northeastern University Nano Coating Technology
Tyber Medical, LLC, a privately held medical device company focused on developing innovative orthopedic and spine devices for private label opportunities, announces FDA clearance of BioTy™, a Modified Surface Treatment for use on their Headless Screw System.
The research occurring at Northeastern University with BioTy™ is focused on providing a preventative long term solution to minimize the risk of health care associated infections on medical devices.
"We have shown, for the first time, that nano-scale surface features alone can reduce implant infection without resorting to the use of antibiotics, which has clearly been shown over the past decade to be a failed attempt to eradicate implant infections. The process we are developing with Tyber Medical is destined to revolutionize the medical device field,” said Dr.Thomas J. Webster, Principal Investigator and the Art Zafiropoulo Chair and Professor of the Department of Chemical Engineering at Northeastern University; President, U.S. Society For Biomaterials; Editor, International Journal of Nanomedicine; and Fellow, AANM, AIMBE, BMES.
“Our research has shown that this versatile surface treatment process alters surface energy to eliminate gram negative, gram positive and even antibiotic resistant bacteria while promoting bone cell functions. It does not employ pharmaceutical agents which can have adverse effects in the body but rather the surface is re-engineered to possess such promising properties.", Webster further remarks.